Candida-specific Th1-type Responsiveness in Mice with Experimental Vaginal Candidiasis

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1993 Oct 1

PMID 8406809

Citations 39

Authors

P L Fidel Jr

M E Lynch

J D Sobel

Affiliations

Soon will be listed here.

Abstract

The role of systemic cell-mediated immunity (CMI) as a host defense mechanism in the vagina is poorly understood. Using a murine pseudoestrus model of experimental vaginal candidiasis, we previously found that animals given a vaginal inoculum of viable Candida albicans blastoconidia acquired a persistent vaginal infection and developed Candida-specific delayed-type hypersensitivity (DTH) responses. The present study was designed to characterize the peripheral CMI reactivity generated from the vaginal infection in mice and to determine whether pseudoestrus is a prerequisite for the induction of peripheral CMI reactivity. Mice treated or not treated with estrogen and given a vaginal inoculum of C. albicans blastoconidia were examined for 4 weeks for their vaginal Candida burden and peripheral CMI reactivity, including DTH responsiveness and in vitro Th1 (interleukin-2 [IL-2], gamma interferon [IFN-gamma]/Th2 (IL-4, IL-10)-type lymphokine production in response to Candida antigens. Results showed that although mice not treated with estrogen before being given a vaginal inoculum of C. albicans blastoconidia developed only a short-lived vaginal infection and harbored significantly fewer Candida CFU in the vagina compared with those given estrogen and then infected; DTH reactivity was equivalent in both groups. In vitro measurement of CMI reactivity further showed that lymph node cells from both estrogen- and non-estrogen-treated infected mice produced elevated levels of IL-2 and IFN-gamma in response to Candida antigens during the 4 weeks after vaginal inoculation. In contrast, lymph node cells from the same vaginally infected mice showed no IL-10 production and only small elevations of IL-4 during week 4 of infection. These results suggest that mice with experimental vaginal candidiasis develop predominantly Th1-type Candida-specific peripheral CMI reactivity and that similar patterns of Th1-type reactivity occur in mice regardless of the persistence of infection and the estrogen status of the infected mice.

Citing Articles

Lab-Based Retrospective 10-Year Analysis Shows Seasonal Variation of Vaginal Infection Rates in Belgium.

Donders G, Ruban K, Donders F, Reybrouck R J Clin Med. 2022; 11(3).

PMID: 35160026 PMC: 8836942. DOI: 10.3390/jcm11030574.

Exogenous Reproductive Hormones nor Candida albicans Colonization Alter the Near Neutral Mouse Vaginal pH.

Miao J, Willems H, Peters B Infect Immun. 2020; 89(2).

PMID: 33106292 PMC: 7822140. DOI: 10.1128/IAI.00550-20.

Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk.

Borghi M, Pariano M, Solito V, Puccetti M, Bellet M, Stincardini C Front Immunol. 2019; 10:2364.

PMID: 31681274 PMC: 6798081. DOI: 10.3389/fimmu.2019.02364.

Antifungal Properties of Chenopodium ambrosioides Essential Oil Against Candida Species.

Chekem M, Lunga P, Tamokou J, Kuiate J, Tane P, Vilarem G Pharmaceuticals (Basel). 2016; 3(9):2900-2909.

PMID: 27713382 PMC: 4034103. DOI: 10.3390/ph3092900.

Systemic inflammation in the extremely low gestational age newborn following maternal genitourinary infections.

Fichorova R, Beatty N, Sassi R, Yamamoto H, Allred E, Leviton A Am J Reprod Immunol. 2014; 73(2):162-74.

PMID: 25164433 PMC: 4293273. DOI: 10.1111/aji.12313.

References

Witkin S, Hirsch J, Ledger W . A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Obstet Gynecol. 1986; 155(4):790-5. DOI: 10.1016/s0002-9378(86)80022-9. View

Witkin S . Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans. Obstet Gynecol. 1986; 68(5):696-9. View

Ryley J, McGregor S . Quantification of vaginal Candida albicans infections in rodents. J Med Vet Mycol. 1986; 24(6):455-60. View

Reynolds D, Boom W, Abbas A . Inhibition of B lymphocyte activation by interferon-gamma. J Immunol. 1987; 139(3):767-73. View

Durandy A, Fischer A, Le Deist F, Drouhet E, Griscelli C . Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J Clin Immunol. 1987; 7(5):400-9. DOI: 10.1007/BF00917018. View

Gajewski T, Fitch F . Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol. 1988; 140(12):4245-52. View

Sobel J . Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci. 1988; 544:547-57. DOI: 10.1111/j.1749-6632.1988.tb40450.x. View

Hu-Li J, OHara J, Watson C, Tsang W, Paul W . Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol. 1989; 142(3):800-7. View

Domer J, Garner R . Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect Immun. 1989; 57(3):693-700. PMC: 313164. DOI: 10.1128/iai.57.3.693-700.1989. View

10.

Bottomly K . A functional dichotomy in CD4+ T lymphocytes. Immunol Today. 1988; 9(9):268-74. DOI: 10.1016/0167-5699(88)91308-4. View

11.

Fiorentino D, Bond M, Mosmann T . Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989; 170(6):2081-95. PMC: 2189521. DOI: 10.1084/jem.170.6.2081. View

12.

Hurley R . Candidal vaginitis. Proc R Soc Med. 1977; 70 Suppl 4:1-2. PMC: 1543203. View

13.

Hobbs J, Brigden D, Davidson F, Kahan M, OATES J . Immunological aspects of candidal vaginitis. Proc R Soc Med. 1977; 70 Suppl 4:11-14. PMC: 1543207. View

14.

Morton R, Rashid S . Candidal vaginitis: natural history, predisposing factors and prevention. Proc R Soc Med. 1977; 70 Suppl 4:3-6. PMC: 1543209. View

15.

Boom W, Liebster L, Abbas A, Titus R . Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect Immun. 1990; 58(12):3863-70. PMC: 313747. DOI: 10.1128/iai.58.12.3863-3870.1990. View

16.

Yssel H, Shanafelt M, Soderberg C, Schneider P, ANZOLA J, Peltz G . Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med. 1991; 174(3):593-601. PMC: 2118948. DOI: 10.1084/jem.174.3.593. View

17.

Tsukada H, Kawamura I, Arakawa M, Nomoto K, Mitsuyama M . Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect Immun. 1991; 59(10):3589-95. PMC: 258925. DOI: 10.1128/iai.59.10.3589-3595.1991. View

18.

Fong I, McCleary P, Read S . Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol. 1992; 166(3):887-90. DOI: 10.1016/0002-9378(92)91356-f. View

19.

Romani L, Mencacci A, Grohmann U, Mocci S, Mosci P, Puccetti P . Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med. 1992; 176(1):19-25. PMC: 2119284. DOI: 10.1084/jem.176.1.19. View

20.

Perito S, Calabresi A, Romani L, Puccetti P, Bistoni F . Involvement of the Th1 subset of CD4+ T cells in acquired immunity to mouse infection with Trypanosoma equiperdum. Cell Immunol. 1992; 143(2):261-71. DOI: 10.1016/0008-8749(92)90024-j. View